The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

Eli Lilly has agreed ... value of up to $1.7 billion. Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions ...

A look back at the horrible loss of life. By Hannah Beech A global crackdown on fentanyl has led cartels to innovate production methods and test their risky formulas on people, as well as ...

According to the NYPD, a 58-year-old cab driver suffered a medical episode when he drove onto the sidewalk at West 34th Street and Sixth Avenue. A man accused of attempting to assassinate ...

Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...

A mysterious inscription on an ancient Sphinx that puzzled scientists for decades has finally been deciphered as Greek writing. For decades, scholars examined the drawing, attempting to decode the ...